Renata’s profits rise 22pc
Profits of Renata Ltd, a listed drug maker, soared over 22 per cent year-on-year to Tk 506 crore in 2020-21 amid the ongoing Covid-19 pandemic.
On the basis of its profit, the pharmaceutical company's board of directors recommended 145 per cent cash and 10 per cent stock dividends for shareholders.
The company made this announcement during a board meeting held yesterday.
The company's earnings per share stood at Tk 51.94 in the recently concluded financial year while it was Tk 46.62 the year before.
Renata got listed with the Dhaka Stock Exchange (DSE) in 1979 and now has a paid-up capital of Tk 97.4 crore, according to DSE data.
Sponsors and directors collectively hold a 51.18 per cent stake in the company.
Comments